Joe Sterling

Analyst Buzz: Cypress Semiconductor Corporation (NASDAQ:CY)

Cypress Semiconductor Corporation (NASDAQ:CY) share price soared 1.30% or 0.18 points to reach at $14.02 during previous trading session. The stock’s price fluctuated within the range of $13.76 – $14.08 during previous trading session. A total of 6.60M shares exchanged hands, whereas the company’s average trading volume stands at 5.97M shares. Cypress Semiconductor Corporation (NASDAQ:CY) has a market capitalization of $4.55B and most recently 287.89M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Cypress Semiconductor Corporation (NASDAQ:CY) is at 64.49.

According to sentiments of 12 analysts the mean estimates of short term price target for the company’s stock is marked at $13.79. The most optimistic analyst sees the stock reaching $16.00 while the most conventional predicts the target price at $11.00.

The consensus means EPS for the current quarter is at $0.11 derived from a total of 12 estimates. According to analysts minimum EPS for the current quarter is expected at $0.11 and can go high up to $0.11. However a year ago during same quarter Cypress Semiconductor Corporation (NASDAQ:CY) reported $0.07 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.15 per share according to consensus of 12 analysts.

According to sentiments of 11 analysts the company is expected to report revenues of $511.39M for the current quarter. Bearish revenue estimates established at $510M while the bullish revenue forecast has been figured out at $520.1M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.31 on the shares of Cypress Semiconductor Corporation (NASDAQ:CY). Out of rating recommendations 2 have given the stock a Buy while 5 recommend the stock as Outperform. 6 have given the stock a Hold rating, 0 as Underperform 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Cypress Semiconductor Corporation (NASDAQ:CY) distance from 20 day simple moving average is 3.58% whereas its distance from 50 day simple moving average is 10.28% along with 23.26% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Cypress Semiconductor Corporation (NASDAQ:CY) shares were trading -1.89% below from the 52-week high mark of $14.29 and 80.29% above from the 52-week bottom of $7.78. The stock hit its 52-week high price on 03/21/17, and 52-week low price on 04/12/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.79% in the past one week and soared 6.94% during previous one month drive, the stock went up 19.44% during past quarter. In the last six months the stock’s performance soared 2.06% while yearly performance of the company advanced 73.16%. The company’s year to date (YTD) performance is at 22.55%.

While taking a glance at financials, we can look at a number of key indicators. Cypress Semiconductor Corporation (NASDAQ:CY) has a Return on Assets (ROA) of -18.40%. The company currently has a Return on Equity (ROE) of -33.20% and a Return on Investment (ROI) of -19.70%. Average true range (ATR-14) of the company sets at 0.33, along with its weekly and monthly volatility of 2.42%, 2.46% respectively. Beta value of the stock stands at 1.96.

The company’s price to free cash flow for trailing twelve months is 247.16. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.30. Total debt to equity ratio of the company for most recent quarter is 0.65 whereas long term debt to equity ratio for most recent quarter is 0.63.

Stock in the Spotlight: Vipshop Holdings Ltd – ADR (NYSE:VIPS)

Vipshop Holdings Ltd – ADR (NYSE:VIPS) share price soared 0.15% or 0.02 points to reach at $13.80 during previous trading session. The stock’s price fluctuated within the range of $13.76 – $14.02 during previous trading session. A total of 7.03M shares exchanged hands, whereas the company’s average trading volume stands at 6.62M shares. Vipshop Holdings Ltd – ADR (NYSE:VIPS) has a market capitalization of $8.25B and most recently 100.15M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Vipshop Holdings Ltd – ADR (NYSE:VIPS) is at 60.050.

According to sentiments of 22 analysts the mean estimates of short term price target for the company’s stock is marked at $16.26. The most optimistic analyst sees the stock reaching $20.05 while the most conventional predicts the target price at $11.03.

The consensus means EPS for the current quarter is at $0.18 derived from a total of 11 estimates. According to analysts minimum EPS for the current quarter is expected at $0.15 and can go high up to $0.2. However a year ago during same quarter Vipshop Holdings Ltd – ADR (NYSE:VIPS) reported $0.15 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.19 per share according to consensus of 9 analysts.

According to sentiments of 9 analysts the company is expected to report revenues of $2.26B for the current quarter. Bearish revenue estimates established at $2.21B while the bullish revenue forecast has been figured out at $2.29B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.92 on the shares of Vipshop Holdings Ltd – ADR (NYSE:VIPS). Out of rating recommendations 10 have given the stock a Buy while 9 recommend the stock as Outperform. 6 have given the stock a Hold rating, 1 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Vipshop Holdings Ltd – ADR (NYSE:VIPS) distance from 20 day simple moving average is 3.32% whereas its distance from 50 day simple moving average is 12.32% along with 6.63% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Vipshop Holdings Ltd – ADR (NYSE:VIPS) shares were trading -20.74% below from the 52-week high mark of $17.14 and 35.16% above from the 52-week bottom of $10.21. The stock hit its 52-week high price on 08/16/16, and 52-week low price on 05/23/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -4.03% in the past one week and soared 2.91% during previous one month drive, the stock went up 24.10% during past quarter. In the last six months the stock’s performance fell -1.15% while yearly performance of the company advanced 11.20%. The company’s year to date (YTD) performance is at 25.34%.

While taking a glance at financials, we can look at a number of key indicators. Vipshop Holdings Ltd – ADR (NYSE:VIPS) has a Return on Assets (ROA) of 9.50%. The company currently has a Return on Equity (ROE) of 41.80% and a Return on Investment (ROI) of 16.10%. Average true range (ATR-14) of the company sets at 0.45, along with its weekly and monthly volatility of 3.25%, 2.95% respectively. Beta value of the stock stands at 1.67.

The company’s quick ratio for most recent quarter is 0.70 along with current ratio for most recent quarter of 1.00. Total debt to equity ratio of the company for most recent quarter is 0.76 whereas long term debt to equity ratio for most recent quarter is 0.76.

Stock to Track: Five Below Inc (NASDAQ:FIVE)

Five Below Inc (NASDAQ:FIVE) share price soared 10.81% or 4.12 points to reach at $42.25 during previous trading session. The stock’s price fluctuated within the range of $40.40 – $43.09 during previous trading session. A total of 7.94M shares exchanged hands, whereas the company’s average trading volume stands at 1.01M shares. Five Below Inc (NASDAQ:FIVE) has a market capitalization of $2.28B and most recently 54.88M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Five Below Inc (NASDAQ:FIVE) is at 64.38.

According to sentiments of 15 analysts the mean estimates of short term price target for the company’s stock is marked at $48.53. The most optimistic analyst sees the stock reaching $57.00 while the most conventional predicts the target price at $38.00.

The consensus means EPS for the current quarter is at $0.9 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.88 and can go high up to $1.08. However a year ago during same quarter Five Below Inc (NASDAQ:FIVE) reported $0.77 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.14 per share according to consensus of 13 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $393.89M for the current quarter. Bearish revenue estimates established at $386.6M while the bullish revenue forecast has been figured out at $468.31M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.94 on the shares of Five Below Inc (NASDAQ:FIVE). Out of rating recommendations 6 have given the stock a Buy while 5 recommend the stock as Outperform. 5 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Five Below Inc (NASDAQ:FIVE) distance from 20 day simple moving average is 8.98% whereas its distance from 50 day simple moving average is 7.71% along with 0.34% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Five Below Inc (NASDAQ:FIVE) shares were trading -19.83% below from the 52-week high mark of $52.70 and 20.61% above from the 52-week bottom of $35.03. The stock hit its 52-week high price on 07/27/16, and 52-week low price on 1/04/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 7.64% in the past one week and soared 6.18% during previous one month drive, the stock went up 4.04% during past quarter. In the last six months the stock’s performance soared 2.50% while yearly performance of the company advanced 1.71%. The company’s year to date (YTD) performance is at 5.73%.

While taking a glance at financials, we can look at a number of key indicators. Five Below Inc (NASDAQ:FIVE) has a Return on Assets (ROA) of 15.20%. The company currently has a Return on Equity (ROE) of 23.70% and a Return on Investment (ROI) of 23.70%. Average true range (ATR-14) of the company sets at 1.51, along with its weekly and monthly volatility of 3.63%, 3.63% respectively. Beta value of the stock stands at 0.97.

The company’s price to free cash flow for trailing twelve months is 54.56. Its quick ratio for most recent quarter is 0.70 along with current ratio for most recent quarter of 2.30.

Analysts Review on Price Target Estimates: Seadrill Ltd (NYSE:SDRL)

Seadrill Ltd (NYSE:SDRL) soared 3.62% during previous trade, a total of 9.20M shares exchanged hands compared with its average trading volume of 16.61M shares whereas its relative volume is 0.66. The stock has a market capitalization of $700.70M along with 504.44M outstanding shares. Stock’s intraday price range hit the peak level of $1.43 and touched the lowest level of $1.35.

Most recently Seadrill Ltd (NYSE:SDRL)’s price target was revised on 03/17/17 and according to 8 analysts stock’s price will reach at $2.45 during 52 weeks with standard deviation of 2.43. Stock’s minimum price target estimates has been figured out at $0.00 while the maximum price target forecast is established at $9, if we look at the price target with an optimistic approach it has upside potential of 529% from its latest closing price of $1.43.

Historically, if we look at price target revisions, two weeks ago Seadrill Ltd (NYSE:SDRL)’s price target was revised on 3/2/17 by the analysts, however the bullish price estimates of the stock set at $5 while the bearish estimates kept at $0.60 over the next one year. Stock’s 52-week target was retained at $2.20, the estimates indicates a standard deviation of 2.43.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 4. ABR value is precisely based on brokerage recommendations, where out of 5 brokerage recommendations 0 rate Seadrill Ltd (NYSE:SDRL) stock a Strong Buy, 0 rate the stocks of the company a Buy, 2 rate Hold, 1 rate Sell and 2 recommend a Strong Sell. Most recently on 1/28/16 the stock of Seadrill Ltd (NYSE:SDRL) downgraded by Morgan Stanley from Overweight to Equal-Weight. However previously on 1/20/17 it was downgraded by BofA/Merrill: from Neutral to Underperform. A research note issued on 9/3/15 the stock was downgraded by Credit Suisse from Neutral to Underperform.

Seadrill Ltd (NYSE:SDRL) performance over the past one year plunged -60.06% whereas its year to date (YTD) performance indicated a bearish trend of -58.06%. During the last six months the stock slipped -29.90%. Quarterly performance of the company shows declining momentum of -61.46% while its last one month trend is negative with -33.49%. Stock’s weekly performance expressed down trend of -0.69%.

The company’s price sits -32.72% below from its 50-day moving average of $1.69 and -45.83% below from the stock’s 200-day moving average which is $2.46. Seadrill Ltd (NYSE:SDRL)’s shares are currently trading -72.55% away from the 52-week high price of $5.21 and +40.20% far from the 52-week low price of $1.02.

According to 14 analysts, Seadrill Ltd (NYSE:SDRL)’s revenue estimates for the current quarter are $667M meanwhile the company has high revenue estimates of $726.8M in contradiction of low revenue estimates of $615.2M. For the current year the company’s revenue estimates are $3.71B compared to low analyst estimates of $3.02B and high estimates of $4.33B according to the projection of 21 analysts.

Stock Buzz: Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Idera Pharmaceuticals Inc (NASDAQ:IDRA) share price soared 19.14% or 0.40 points to reach at $2.49 during previous trading session. The stock’s price fluctuated within the range of $2.24 – $2.54 during previous trading session. A total of 8.78M shares exchanged hands, whereas the company’s average trading volume stands at 1.40M shares. Idera Pharmaceuticals Inc (NASDAQ:IDRA) has a market capitalization of $347.94M and most recently 149.09M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Idera Pharmaceuticals Inc (NASDAQ:IDRA) is at 74.77.

According to sentiments of 2 analysts the mean estimates of short term price target for the company’s stock is marked at $5. The most optimistic analyst sees the stock reaching $6 while the most conventional predicts the target price at $4.

The consensus mean EPS for the current quarter is at $-0.1 derived from a total of 3 estimates. According to analysts minimum EPS for the current quarter is expected at $-0.11 and can go high up to $-0.09. However a year ago during same quarter Idera Pharmaceuticals Inc (NASDAQ:IDRA) reported $-0.11 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $-0.11 per share according to consensus of 3 analysts.

According to sentiments of 1 analyst the company is expected to report revenues of $300K for the current quarter. Bearish revenue estimates established at $300K while the bullish revenue forecast has been figured out at $300K.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.75 on the shares of Idera Pharmaceuticals Inc (NASDAQ:IDRA). Out of rating recommendations 1 have given the stock a Buy while 3 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s distance from 20 day simple moving average is 30.98% whereas its distance from 50 day simple moving average is 48.25% along with 40.64% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares were trading -25.23% below from the 52-week high mark of $3.33 and +109.24% above from the 52-week bottom of $1.19. The stock hit its 52-week high price on 9/26/16 and 52-week low price on 5/10/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 36.07% in the past one week and soared 50% during previous one month drive, the stock went up 55.62% during past quarter. In the last six months the stock’s performance plunged -12.32% while yearly performance of the company advanced 16.36%.The company’s year to date (YTD) performance is at 66%.

While taking a glance at financials, we can look at a number of key indicators. Idera Pharmaceuticals Inc (NASDAQ:IDRA) has a Return on Assets (ROA) of -47.90%. The company currently has a Return on Equity (ROE) of -53.50% and a Return on Investment (ROI) of -37.30%.. Average true range (ATR-14) of the company sets at 0.16, along with its weekly and monthly volatility of 10.59%, 7.41% respectively. Beta value of the stock stands at 2.45.

The company’s quick ratio for most recent quarter is 11.90 along with current ratio for most recent quarter of 11.90. Total debt to equity ratio of the company for most recent quarter is 0.00 whereas long term debt to equity ratio for most recent quarter is 0.00.

Stock in Limelight: Cerulean Pharma Inc (NASDAQ:CERU)

Cerulean Pharma Inc (NASDAQ:CERU) share price plunged -8.20% or -0.10 points to reach at $1.12 during previous trading session. The stock’s price fluctuated within the range of $1.06 – $1.23 during previous trading session. A total of 7.12M shares exchanged hands, whereas the company’s average trading volume stands at 5.33M shares. Cerulean Pharma Inc (NASDAQ:CERU) has a market capitalization of $30.73M and most recently 24.77M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Cerulean Pharma Inc (NASDAQ:CERU) is at 42.88.

According to sentiments of 2 analysts the mean estimates of short term price target for the company’s stock is marked at $3.75. The most optimistic analyst sees the stock reaching $6.00 while the most conventional predicts the target price at $1.50.

The consensus means EPS for the current quarter is at -$0.34 derived from a total of 2 estimates. According to analysts minimum EPS for the current quarter is expected at -$0.37 and can go high up to -$0.3. However a year ago during same quarter Cerulean Pharma Inc (NASDAQ:CERU) reported -$0.39 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of -$0.31 per share according to consensus of 1 analysts.

According to sentiments of 1 analysts the company is expected to report revenues of $5M for the current quarter. Bearish revenue estimates established at $5M while the bullish revenue forecast has been figured out at $5M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.33 on the shares of Cerulean Pharma Inc (NASDAQ:CERU). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 2 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Cerulean Pharma Inc (NASDAQ:CERU) distance from 20 day simple moving average is -34.27% whereas its distance from 50 day simple moving average is -13.57% along with -19.63% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Cerulean Pharma Inc (NASDAQ:CERU) shares were trading -74.13% below from the 52-week high mark of $4.33 and 77.69% above from the 52-week bottom of $0.63. The stock hit its 52-week high price on 04/21/16, and 52-week low price on 11/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -62.42% in the past one week and plunged -17.04% during previous one month drive, the stock went up 43.02% during past quarter. In the last six months the stock’s performance soared 17.89% while yearly performance of the company fell -55.56%. The company’s year to date (YTD) performance is at 58.15%.

While taking a glance at financials, we can look at a number of key indicators. Cerulean Pharma Inc (NASDAQ:CERU) has a Return on Assets (ROA) of -77.90%. The company currently has a Return on Equity (ROE) of -141.70%. Average true range (ATR-14) of the company sets at 0.43, along with its weekly and monthly volatility of 21.88%, 15.20% respectively.

The company’s quick ratio for most recent quarter is 2.50 along with current ratio for most recent quarter of 2.50. Total debt to equity ratio of the company for most recent quarter is 0.89 whereas long term debt to equity ratio for most recent quarter is 0.40.

Analyst’s Review on: Abraxas Petroleum Corp. (NASDAQ:AXAS)

Abraxas Petroleum Corp. (NASDAQ:AXAS) share price soared 5.67% or 0.11 points to reach at $2.05 during previous trading session. The stock’s price fluctuated within the range of $1.87 – $2.05 during previous trading session. A total of 2.99M shares exchanged hands, whereas the company’s average trading volume stands at 2.60M shares. Abraxas Petroleum Corp. (NASDAQ:AXAS) has a market capitalization of $310.29M and most recently 163.84M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Abraxas Petroleum Corp. (NASDAQ:AXAS) is at 50.04.

According to sentiments of 8 analysts the mean estimates of short term price target for the company’s stock is marked at $3.02. The most optimistic analyst sees the stock reaching $3.75 while the most conventional predicts the target price at $2.00.

The consensus means EPS for the current quarter is at $0.02 derived from a total of 7 estimates. According to analysts minimum EPS for the current quarter is expected at $0.02 and can go high up to $0.04. However a year ago during same quarter Abraxas Petroleum Corp. (NASDAQ:AXAS) reported -$0.01 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.03 per share according to consensus of 7 analysts.

According to sentiments of 6 analysts the company is expected to report revenues of $21.14M for the current quarter. Bearish revenue estimates established at $18.66M while the bullish revenue forecast has been figured out at $23.6M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.62 on the shares of Abraxas Petroleum Corp. (NASDAQ:AXAS). Out of rating recommendations 4 have given the stock a Buy while 3 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Abraxas Petroleum Corp. (NASDAQ:AXAS) distance from 20 day simple moving average is 3.27% whereas its distance from 50 day simple moving average is -10.50% along with 14.29% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Abraxas Petroleum Corp. (NASDAQ:AXAS) shares were trading -31.44% below from the 52-week high mark of $2.99 and 130.34% above from the 52-week bottom of $0.89. The stock hit its 52-week high price on 01/05/17, and 52-week low price on 04/05/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 15.17% in the past one week and plunged -8.89% during previous one month drive, the stock went down -19.61% during past quarter. In the last six months the stock’s performance soared 37.58% while yearly performance of the company advanced 89.81%. The company’s year to date (YTD) performance is at -20.23%.

While taking a glance at financials, we can look at a number of key indicators. Abraxas Petroleum Corp. (NASDAQ:AXAS) has a Return on Assets (ROA) of -55.00%. The company currently has a Return on Equity (ROE) of -345.90% and a Return on Investment (ROI) of -63.30%. Average true range (ATR-14) of the company sets at 0.15, along with its weekly and monthly volatility of 10.03%, 7.52% respectively. Beta value of the stock stands at 1.44.

The company’s quick ratio for most recent quarter is 0.80 along with current ratio for most recent quarter of 0.80. Total debt to equity ratio of the company for most recent quarter is 5.26 whereas long term debt to equity ratio for most recent quarter is 5.22.

Stock Earnings on Trader’s Radar: Steelcase Inc. (NYSE:SCS)

Shares of Steelcase Inc. (NYSE:SCS) reached at $15.70 during previous trading session. The company has experienced volume of 1,303,276 shares.

Steelcase Inc. (NYSE:SCS) on March 22, 2017 reported fourth quarter revenue of $769.1 million and net income of $25.8 million, or diluted earnings of $0.21 per share.  During the quarter, as a result of a change in the French corporate tax rate, the company reduced the value of its net deferred tax assets by approximately $8 million, which reduced diluted earnings per share by approximately $0.06, net of related variable compensation effects.  In the prior year, Steelcase reported $747.9 million of revenue, diluted earnings of $0.62 per share and adjusted earnings of $0.64 per share.  Prior year results included significant items related to the reversal of a valuation allowance recorded against net deferred tax assets in France and a gain from the partial sale of an investment in an unconsolidated affiliate, which had a combined favorable impact on diluted earnings per share of approximately $0.42, net of related variable compensation expense.

Revenue increased 3 percent in the fourth quarter compared to the prior year, while orders increased by 6 percent. The Americas posted revenue growth of 3 percent, which was negatively impacted by continued year-over-year declines in the energy sector. Orders in the Americas grew 5 percent over the prior year.  EMEA revenue declined 5 percent, or less than 1 percent on an organic basis, and orders declined 3 percent, reflecting mixed results across the region.  The Other category posted revenue growth of 13 percent and order growth of 24 percent in the fourth quarter compared to prior year, driven by continued strength in Asia Pacific.

Steelcase Inc. (NYSE:SCS) holds the market capitalization of $1.87B along with 85.90M outstanding shares. During the last trade, stock’s minimum price has been reached out at $15.45 while the maximum trading price moved at $16.25. Currently the stock price is moving -9.59% off from the highest level of twelve months and +31.46% above from twelve months low. Steelcase Inc. (NYSE:SCS) marked 52-week highest price level of $18.14 on 12/30/16 and 52-week lowest price level of $12.48 on 09/21/16. For the stock, price target value has been calculated at $18.00 based on calls of 1 experts. Stock’s minimum price target estimates has been figured out at $18.00 while the maximum price target forecast is established at $18.00.

As of current trade, Steelcase Inc. (NYSE:SCS) has shown weekly downbeat performance of -5.42%. Its six months performance indicated a bullish movement while its yearly performance reflected a positive trend of 9.27%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -12.29%. Shares of Steelcase Inc. (NYSE:SCS) currently have an ABR of 3.00, derived from a total of 3 opinions. The company’s price sits 0.06% above from its 50-day moving average of $16.34 and 8.97% above from the stock’s 200-day moving average of $15.48. The company has Relative Strength Index (RSI 14) of 51.41 along with Average True Range (ATR 14) of 0.44. Its weekly and monthly volatility is 3.18%, 2.62% respectively. The company’s beta value is at 1.07.

Steelcase Inc. (NYSE:SCS) currently has a PEG ratio of 1.16 where as its P/E ratio is 10.89. The company’s price to sales ratio for trailing twelve months is 0.61 and price to book ratio for most recent quarter is 2.49, whereas price to cash per share for the most recent quarter is 7.81. Steelcase Inc. (NYSE:SCS)’s price to free cash flow for trailing twelve months is 48.34. Its quick ratio for most recent quarter is 1.20 along with current ratio for most recent quarter of 1.50. Total debt to equity ratio of the company for most recent quarter is 0.40 whereas long term debt to equity ratio for most recent quarter is 0.40. Steelcase Inc. (NYSE:SCS) has a Return on Assets of 9.90%. The company currently has a Return on Equity of 23.30% and Return on Investment of 16.40%.

Analysts Reviews Summary: UnitedHealth Group Inc (NYSE:UNH)

UnitedHealth Group Inc (NYSE:UNH) plunged -0.18% during previous trade, a total of 4.95M shares exchanged hands compared with its average trading volume of 3.50M shares whereas its relative volume is 1.45. The stock has a market capitalization of $156.44B along with 951.17M outstanding shares. Stock’s intraday price range hit the peak level of $168.82 and touched the lowest level of $167.06.

Most recently UnitedHealth Group Inc (NYSE:UNH)’s price target was revised on 3/16/17 and according to 20 analysts stock’s price will reach at $184.80 during 52 weeks with standard deviation of 16.95. Stock’s minimum price target estimates has been figured out at $145 while the maximum price target forecast is established at $210, if we look at the price target with an optimistic approach it has upside potential of 25% from its latest closing price of $167.70.

Historically, if we look at price target revisions, two weeks ago UnitedHealth Group Inc (NYSE:UNH)’s price target was revised on 2/27/17 by the analysts, however the bullish price estimates of the stock set at $210 while the bearish estimates kept at $155 over the next one year. Stock’s 52-week target was retained at $180.53, the estimates indicates a standard deviation of 14.91.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.29. ABR value is precisely based on brokerage recommendations, where out of 17 brokerage recommendations 15 rate UnitedHealth Group Inc (NYSE:UNH) stock a Strong Buy, 1 rate the stocks of the company a Buy, 0 rate Hold, 0 rate Sell and 1 recommend a Strong Sell. Most recently on 12/7/16 the stock of UnitedHealth Group Inc (NYSE:UNH) upgraded by Cantor Fitzgerald from Hold to Buy. However previously on 11/30/16 it was upgraded by Mizuho from Neutral to Buy. A research note issued on 11/9/16 the stock was downgraded by Mizuho from Buy to Neutral.

UnitedHealth Group Inc (NYSE:UNH) performance over the past one year soared 34.57% whereas its year to date (YTD) performance indicated a bullish trend of 5.18%. During the last six months the stock climbed 22.75%. Quarterly performance of the company shows optimistic momentum of 2.67% while its last one month trend is positive with 6.79%. Stock’s weekly performance expressed down trend of -0.80%.

The company’s price sits 2.80% above from its 50-day moving average of $164.76 and 13.35% far from the stock’s 200-day moving average which is $153.14. UnitedHealth Group Inc (NYSE:UNH)’s shares are currently trading -2.58% away from the 52-week high price of $172.14 and +36.16% far from the 52-week low price of $123.17.

According to consensus agreement of 18 analysts UnitedHealth Group Inc (NYSE:UNH) will report earnings per share of $2.17 in their quarterly report and it is expected to announce the company’s results on 4/18/17. For the current quarter the company has high EPS estimates of $2.3 in contradiction of low EPS estimates of $2.04. However a year ago for the same quarter the company has reported $1.81 EPS. Current year EPS projections for UnitedHealth Group Inc (NYSE:UNH) set at $9.51 according to the sentiments of 23 analysts, while its lowest earnings estimates are $9.43 and highest earnings estimates are $9.63.

According to 14 analysts, UnitedHealth Group Inc (NYSE:UNH)’s revenue estimates for the current quarter are $48.25B meanwhile the company has high revenue estimates of $49.11B in contradiction of low revenue estimates of $47.5B. For the current year the company’s revenue estimates are $198.93B compared to low analyst estimates of $196.43B and high estimates of $201.39B according to the projection of 15 analysts.

Stock to Track: CSX Corporation (NASDAQ:CSX)

CSX Corporation (NASDAQ:CSX) share price plunged -2.69% or -1.26 points to reach at $45.62 during previous trading session. The stock’s price fluctuated within the range of $45.41 – $47.04 during previous trading session. A total of 17,272,200 shares exchanged hands, whereas the company’s average trading volume stands at 12.80M shares. CSX Corporation (NASDAQ:CSX) has a market capitalization of $41.63B and most recently 926.45M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for CSX Corporation (NASDAQ:CSX) is at 37.72.

According to sentiments of 25 analysts the mean estimates of short term price target for the company’s stock is marked at $52.36. The most optimistic analyst sees the stock reaching $65.00 while the most conventional predicts the target price at $35.00.

The consensus means EPS for the current quarter is at $0.42 derived from a total of 28 estimates. According to analysts minimum EPS for the current quarter is expected at $0.35 and can go high up to $0.47. However a year ago during same quarter CSX Corporation (NASDAQ:CSX) reported $0.37 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.54 per share according to consensus of 28 analysts.

According to sentiments of 21 analysts the company is expected to report revenues of $2.75B for the current quarter. Bearish revenue estimates established at $2.48B while the bullish revenue forecast has been figured out at $2.82B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.03 on the shares of CSX Corporation (NASDAQ:CSX). Out of rating recommendations 11 have given the stock a Buy while 8 recommend the stock as Outperform. 10 have given the stock a Hold rating, 1 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. CSX Corporation (NASDAQ:CSX) distance from 20 day simple moving average is -5.31% whereas its distance from 50 day simple moving average is -0.59% along with 34.12% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. CSX Corporation (NASDAQ:CSX) shares were trading -9.32% below from the 52-week high mark of $50.31 and 92.22% above from the 52-week bottom of $23.73. The stock hit its 52-week high price on 03/07/17, and 52-week low price on 04/11/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -4.62% in the past one week and plunged -5.30% during previous one month drive, the stock went up 27.54% during past quarter. In the last six months the stock’s performance soared 57.85% while yearly performance of the company advanced 75.64%. The company’s year to date (YTD) performance is at 27.93%.

While taking a glance at financials, we can look at a number of key indicators. CSX Corporation (NASDAQ:CSX) has a Return on Assets (ROA) of 4.90%. The company currently has a Return on Equity (ROE) of 14.70% and a Return on Investment (ROI) of 9.80%. Average true range (ATR-14) of the company sets at 0.96, along with its weekly and monthly volatility of 1.91%, 1.94% respectively. Beta value of the stock stands at 1.29.

The company’s quick ratio for most recent quarter is 1.00 along with current ratio for most recent quarter of 1.20. Total debt to equity ratio of the company for most recent quarter is 0.97 whereas long term debt to equity ratio for most recent quarter is 0.94.